09:30 EDT EXACT Sciences (EXAS) trading halted, volatility trading pause
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Exact Sciences: Strategic Positioning and Growth Potential Bolstered by Freenome Agreement
- Exact Sciences: Strategic Moves and Strong Performance Justify Buy Rating Despite Market Overreaction
- Exact Sciences price target lowered to $55 from $65 at Barclays
- Exact Sciences Corp. Reports Strong Q2 2025 Results
- Closing Bell Movers: DoorDash jumps 8%, Airbnb slips 6% on earnings